Tax

Deferred Foreign Tax Expense (Benefit)

HCA Healthcare Deferred Foreign Tax Expense (Benefit) remained flat by 0.0% to $1.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 14.3%, from $1.75M to $1.50M. Over 4 years (FY 2021 to FY 2025), Deferred Foreign Tax Expense (Benefit) shows a downward trend with a -14.1% CAGR.

Analysis

StatementIncome Statement
SectionTax
First reportedQ1 2017
Last reportedQ4 2025Feb 10, 2026
Metric ID: unp_deferred_foreign_tax

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$11.00M$12.00M$19.00M$7.00M$6.00M
YoY Change—+9.1%+58.3%-63.2%-14.3%
Range$6.00M – $19.00M
CAGR-14.1%
Avg YoY Growth-2.5%
Median YoY Growth-2.6%
Current Streak2 years decline

Frequently Asked Questions

What is HCA Healthcare's deferred foreign tax expense (benefit)?
HCA Healthcare (HCA) reported deferred foreign tax expense (benefit) of $1.50M in Q4 2025.
How has HCA Healthcare's deferred foreign tax expense (benefit) changed year-over-year?
HCA Healthcare's deferred foreign tax expense (benefit) decreased by 14.3% year-over-year, from $1.75M to $1.50M.
What is the long-term trend for HCA Healthcare's deferred foreign tax expense (benefit)?
Over 4 years (2021 to 2025), HCA Healthcare's deferred foreign tax expense (benefit) has grown at a -14.1% compound annual growth rate (CAGR), from $11.00M to $6.00M.